Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR–ABL-Negative Myeloproliferative Neoplasm
Alessandro Allegra, Giovanni Pioggia, Alessandro Tonacci, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1037-1037
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Oxidative Stress in Cancer Cell Metabolism
Saniya Arfin, Niraj Kumar Jha, Saurabh Kumar Jha, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 642-642
Open Access | Times Cited: 444
Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies
Vincenzo Nasillo, Giovanni Riva, Ambra Paolini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1906-1906
Open Access | Times Cited: 28
CEACAM5 exacerbates asthma by inducing ferroptosis and autophagy in airway epithelial cells through the JAK/STAT6-dependent pathway
Si Liu, Li Chen, Yunxiao Shang
Redox Report (2025) Vol. 30, Iss. 1
Open Access
Chaetoglobosin A induces apoptosis in T-24 human bladder cancer cells through oxidative stress and MAPK/PI3K-AKT-mTOR pathway
Jia Song, Jinyu Qiao, Mingxue Chen, et al.
PeerJ (2025) Vol. 13, pp. e19085-e19085
Open Access
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
Yu‐Hung Wang, Hsin‐An Hou, Chien‐Chin Lin, et al.
Blood Advances (2021) Vol. 5, Iss. 22, pp. 4535-4548
Open Access | Times Cited: 26
Effect of Diet and Oxidative Stress in the Pathogenesis of Lymphoproliferative Disorders
Gabriella Cancemi, Nicola Cicero, Alessandro Allegra, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1674-1674
Open Access | Times Cited: 9
Phytochemical characterization and assessment of antitumor activity of the aqueous extract of Acmella caulirhiza in female Wistar rats induced by 7,12 dimethylbenz (a) anthracene
Huiny Miriane Tienoue Fotso, Mary-Ann Mbong Angie, Françoise Raïssa Ntentié, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100527-100527
Open Access | Times Cited: 3
A concise review on the bioactive potential of the genus Gracilaria (Rhodophyta)
Alka Rani, Khem Chand Saini, Meenakshi Fartyal, et al.
The Nucleus (2024)
Closed Access | Times Cited: 3
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients
Renata Mangione, Cesarina Giallongo, Andrea Duminuco, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 490-490
Open Access | Times Cited: 3
PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph(-) Myeloproliferative Neoplasm: A Review
Jen C. Wang, Lishi Sun
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5837-5837
Open Access | Times Cited: 14
The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation
Jing Ming, Weiyi Liu, Hongwei Wu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111767-111767
Open Access | Times Cited: 17
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis
Elena Genovese, Margherita Mirabile, Sebastiano Rontauroli, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 113-113
Open Access | Times Cited: 12
Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms
Vibe Skov, Mads Thomassen, Lasse Kjær, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0270669-e0270669
Open Access | Times Cited: 12
Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?
Alessandro Allegra, Alessandro Tonacci, Laura Giordano, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1696-1696
Open Access | Times Cited: 12
Retinal Vessel Analysis and Microvascular Abnormalities in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
Anna Maria Roszkowska, Rossana Leanza, Emanuela Aragona, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2232-2232
Open Access | Times Cited: 2
Polycythemia vera: past, present and future
Ami B. Patel, Lucia Masárová, Ruben A. Mesa, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-13
Closed Access | Times Cited: 2
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia‐chromosome negative myeloproliferative neoplasms
Vibe Skov, Mads Thomassen, Lasse Kjær, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 5, pp. 805-814
Open Access | Times Cited: 5
Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
Yammy Yung, Emily Lee, Hiutung Chu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 659-659
Open Access | Times Cited: 12
Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma
Giuseppe Murdaca, Alessandro Allegra, Francesca Paladin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9039-9039
Open Access | Times Cited: 12
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases
Enrico La Spina, Sebastiano Giallongo, Cesarina Giallongo, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Assessment of Total Antioxidant Capacity, 8-Hydroxy-2′-Deoxy-Guanosine, the Genetic Landscape, and Their Associations in BCR::ABL-1-Negative Chronic and Blast Phase Myeloproliferative Neoplasms
Mihnea‐Alexandru Găman, Cristina Mambet, Ana Iulia Neagu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6652-6652
Open Access | Times Cited: 1
Immune‐dysregulation harnessing in myeloid neoplasms
Mohammad Jafar Sharifi, Ling Xu, Nahid Nasiri, et al.
Cancer Medicine (2024) Vol. 13, Iss. 17
Open Access | Times Cited: 1
The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms
Roberta Vadeikienė, Baltramiejus Jakštys, Danguolė Laukaitienė, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9873-9873
Open Access | Times Cited: 1
Understanding triple negative myeloproliferative neoplasms: pathogenesis, clinical features, and management
Serena Tharakan, John Mascarenhas, Douglas Tremblay
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 65, Iss. 2, pp. 158-167
Closed Access | Times Cited: 3
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70—A Retrospective Study
Nora-Medea Messerich, Narasimha Rao Uda, Thomas Volken, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1479-1479
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top